A Barbara Ann Karmanos Cancer Institute and Wayne State University (WSU) School of Medicine researcher is being recognized for his record of prolific scientific publications and the high impact of that work.
Avraham Raz, Ph.D., member of the Tumor Biology and Microenvironment Research Program, an internationally recognized leader in the field of cancer metastasis, and the Paul Zuckerman Professor of Oncology and Pathology, has been named an inaugural Highly Ranked Scholar by ScholarGPS™. The recognition comes as his scholarly contributions place him in the top .05% of all scholars worldwide.
ScholarGPS™ is a continually updated worldwide compilation of metadata of more than 200 million journal papers, books, conference papers, and patents of 30 million scholars.
The organization listed Dr. Raz 24th in the area of metastasis and 30th in motility as one of its lifetime highly ranked scholars. View his ScholarGPS™ profile here.
Dr. Raz is best known for his pioneering work on galectins research in cancer, identifying the first “normal” chimeric gene product (galectin 3) and characterization of a novel cancer motility factor and its receptor that resulted in a new biological concept of “moonlighting proteins.” His groundbreaking discoveries have opened innovative strategies and avenues relevant to understanding cancer cell trafficking and signaling governing metastatic processes. His work has resulted in more than 60 clinical trials, and he has received the National Cancer Institute’s Merit Award.
ScholarGPS™ has Dr. Raz’s count at 273 total publications, over 23,000 predicted citations and an overall predicted h-index of 85. Per Google Scholar, Dr. Raz has an h-index of 102, with over 32,300 citations.
Originally published at Today@Wayne.